Scripps-led consortium scores $129M NIH grant to work on vaccine for stubborn HIV
Scientific effort into developing a vaccine against the HIV has proved elusive, as the virus rapidly mutates and its outer spike protein operates as an invisibility cloak, allowing it to outwit the immune system’s defensive arsenal. On Wednesday, a consortium of scientists led by Scripps Research unveiled a $129 million grant from the National Institutes of Health (NIH) that will help shepherd vaccines — engineered to combat a plethora of HIV strains — into the clinic.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
